HAS Healthcare Advanced Synthesis to acquire Cerbios-Pharma.

HAS Healthcare Advanced Synthesis, an international developer and producer of active pharmaceutical ingredients, agreed to acquire Cerbios-Pharma, a manufacturer of chemical and biological APIs. Financial terms were not disclosed. “We are proud to join HAS Healthcare Advanced Synthesis SA and to significantly contribute to the strength and growth of the new Group. HAS represents the ideal partner to help us accelerate our growth and expand our range of offerings and the value we provide to our clients," Christian Suà, Cerbios-Pharma CEO.